Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
MWN-AI** Summary
Gelteq Limited and Healthy Extracts Inc. have entered into a strategic partnership aimed at accelerating the commercialization of next-generation gel-based nutraceutical products. Officially formalized through a Memorandum of Understanding (MoU) on February 11, 2026, this collaboration builds on Healthy Extracts' past acquisitions of Gelteq’s formulated products, establishing a pathway for large-scale manufacturing and global distribution of novel gel-based solutions.
As part of this partnership, Healthy Extracts will utilize its U.S.-based manufacturing capabilities to produce innovative nutraceutical products using Gelteq's proprietary formulations and expertise. This alignment of Gelteq's cutting-edge gel delivery technology with Healthy Extracts' operational strengths is poised to meet rising global demand for effective, science-backed nutritional formats. The new products will be manufactured in the U.S. and distributed internationally, reinforcing supply-chain reliability and scalability in production.
Both companies will jointly develop marketing strategies and future product lines while ensuring Gelteq retains ownership of its intellectual property. This venture enables Healthy Extracts not only to be the primary manufacturer and distributor for the new range but also to explore white-label options for selected customers.
Gelteq's CEO, Nathan Givoni, emphasized the significance of this partnership in expanding the reach of their gel technologies, which he views as crucial to tapping into new categories and markets. Healthy Extracts' CEO, Don Swanson, highlighted the collaboration's potential to enhance their product pipeline and drive long-term international growth.
Ultimately, this partnership positions both Gelteq and Healthy Extracts to capitalize on the burgeoning demand for advanced nutraceutical delivery systems, with plans for future expansion into regions like China and emerging wellness markets. The finalization of a Manufacturing & Royalty Agreement is anticipated to solidify the commercial terms of this collaboration.
MWN-AI** Analysis
The recent Memorandum of Understanding (MoU) between Gelteq Limited and Healthy Extracts Inc. marks a pivotal moment for both companies in the burgeoning gel-based nutraceutical market. With Gelteq's proprietary gel delivery technology and Healthy Extracts' established manufacturing capabilities, this partnership is poised to capitalize on the increasing consumer demand for innovative nutritional solutions.
From an investment standpoint, this strategic alliance offers several positive signals. First, by leveraging Healthy Extracts' U.S.-based manufacturing infrastructure, Gelteq can significantly enhance its scalability and supply chain reliability. This efficiency is crucial for meeting the anticipated global demand for nutraceutical products in gel form, which are recognized for their superior bioavailability and consumer-friendly delivery.
Moreover, the partnership opens potential avenues for international expansion, particularly into high-growth markets in Asia, such as China, known for its increasing health consciousness and rapid adoption of functional foods. Investors should closely monitor the developing product pipeline and marketing initiatives that both companies plan to pursue, as these could drive revenue growth in the near future.
Furthermore, the prospect of white-labeling products could attract additional revenue streams and partnerships, enhancing the portfolio's overall value. Given that Gelteq retains ownership of its intellectual property, it positions itself strongly for long-term growth and innovation.
However, investors should remain cautious about inherent risks, including competition in a crowded nutraceutical landscape and the regulatory challenges associated with product approvals. Thus, while the partnership presents significant growth opportunities, it's essential to maintain a balanced outlook, considering both the potential rewards and risks involved.
In summary, Gelteq and Healthy Extracts are strategically positioned to lead in the gel-based nutrition sector, making them compelling players for those looking to invest in next-generation health solutions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
MELBOURNE, Australia and LAS VEGAS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) and Healthy Extracts™ Inc. (“Healthy Extracts”) today announced the signing of a Memorandum of Understanding (“MoU”) formalising a strategic partnership designed to accelerate the commercial rollout of next-generation gel-based nutraceutical products. The collaboration builds on Healthy Extracts’ prior purchases of Gelteq-formulated products and marks the first phase of a long-term plan to bring Gelteq’s proprietary gel delivery technology to large-scale US manufacturing and global distribution.
Under the MoU, Healthy Extracts will leverage its established US-based nutritional manufacturing capabilities to produce new gel-based nutraceutical products using Gelteq’s proprietary formulations, technical processes, and expertise. The collaboration enables both companies to combine complementary strengths; Gelteq’s innovation in gel-delivery science and Healthy Extracts’ operational manufacturing excellence and market access.
US-Manufactured Products with Global Distribution
Through this partnership, new gel-based nutraceutical products will be end-to-end manufactured in the United States using Healthy Extracts’ in-house capabilities and then distributed across both domestic and international channels. This structure is designed to support rapidly scalable production, strengthen supply-chain reliability, and meet the growing global demand for novel, science-backed delivery formats in the nutrition category.
Healthy Extracts will serve as the primary manufacturer, commercial seller, and distribution partner for this range of products, with the opportunity available to white-label finished goods for select customers. Gelteq will provide the required technical transfer to enable manufacturing whilst retaining full ownership of its intellectual property. Both companies will collaborate on marketing initiatives and future product development.
Expanding Gelteq’s Technology Into New Applications and Markets
“This partnership marks a significant step in expanding the reach of our gel-based technologies,” said Nathan Givoni, CEO of Gelteq. “Healthy Extracts brings the manufacturing strength and market presence needed to introduce new gel-format nutraceuticals at scale. We’re thrilled to see our technology applied to new product categories and new global markets.”
“This MoU expands our product pipeline with next-generation gel-based nutraceuticals and establishes a clear pathway to scalable U.S. manufacturing and commercial execution,” said Don Swanson, CEO of Healthy Extracts. “We intend to accelerate product rollout, broaden distribution across multiple channels, and support longer-term international expansion, as well as collaborate on additional product development, strategic commercialization initiatives, and expanded market opportunities over time.”
A Commercial Partnership Positioned for Scale
As global demand increases for advanced nutraceutical delivery systems, the companies believe gel-based formats represent one of the next major growth frontiers in functional nutrition. With Healthy Extracts’ manufacturing infrastructure and Gelteq’s proprietary technology, the partnership establishes a pathway to commercialise multiple lines of gel-based products while also opening opportunities for joint expansion into new regions such as China and emerging wellness markets.
Following the signing of the MoU, the companies seek to finalise the full Manufacturing & Royalty Agreement and to formalise commercial terms.
About Gelteq Ltd.
Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a biotechnology company that has developed a novel drug delivery platform in an ingestible gel form. Gelteq specializes in the formulation, development and manufacturing of gel products for licensed partners across pharmaceutical, consumer health and animal health markets. The proprietary formulation technology aims to address challenges associated with conventional drug and nutrient delivery by enhancing bioavailability, improving patient compliance, and enabling precise dosing. For more information, visit www.gelteq.com.
About Healthy Extracts Inc.
Healthy Extracts Inc. (OTCQB: HYEX) develops, manufactures and markets proprietary, science-based supplements for brain, heart, and gut health. The platform is a vertically integrated NutraTech platform leveraging patented oral delivery technologies and strategic acquisitions to scale health and pharmaceutical-adjacent markets that deliver wellness solutions. For more information, visit www.healthyextracts.com
Gelteq Contact:
Investor Relations
Matt Kreps, Darrow Associates IR
+1-214-597-8200
[email protected]
Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained herein are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. For a discussion of these risks and uncertainties, refer to Gelteq’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F filed on November 17, 2025. Gelteq undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
FAQ**
How does Gelteq Limited GELS plan to leverage its gel delivery technology in the competitive nutraceutical market: what specific advantages does it offer over traditional delivery formats?
What potential challenges could Gelteq Limited GELS face when expanding its proprietary gel products into international markets, particularly in emerging regions?
In what ways will Healthy Extracts' manufacturing capabilities enhance the commercialization process for Gelteq Limited GELS’ nutraceutical products in the U.S.?
How will the strategic partnership between Gelteq Limited GELS and Healthy Extracts Inc. impact the overall growth trajectory of the gel-based nutraceutical market in the coming years?
**MWN-AI FAQ is based on asking OpenAI questions about Healthy Extracts Inc. (OTC: HYEX).
NASDAQ: HYEX
HYEX Trading
0.0% G/L:
$2.2238 Last:
108 Volume:
$2.2237 Open:
